'Undervalued': 3 ASX 300 shares to buy following significant share price falls

Experts have named these ASX shares as buys.

| More on:
A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some experts have revealed where they see value within the S&P/ASX 300 Index (ASX: XKO) share landscape.

Share prices are always changing, so when valuations adjust, it can open up opportunities if something moves from being fair value to good value.

In a piece on The Bull, analysts have rated some stocks as a buy, so I'll discuss three below.

Worley Ltd (ASX: WOR)

Worley described itself as a global professional services company of energy, chemicals and resources experts. The company partners with customers to deliver projects and "create value over the life of their assets". It says it's "moving towards more sustainable energy sources, while helping to provide the energy, chemicals and resources now."

It was rated as a buy by Peter Day from Sequoia Wealth Management, who said the company's factored sales pipeline was up 14% in the financial year to 31 March 2024. Sustainable-related work represented 82% of the factored sales pipeline.

The ASX 300 share's plans include growing profit margins through automation and generative artificial intelligence and targeting market share gains with its technology solutions pipeline.

Telstra Group Ltd (ASX: TLS)

The ASX telco share is the leading provider of mobile services in Telstra. It also has a growing presence in cable infrastructure, enterprise, NBN services for households and telco services for Pacific Island nations.

Jabin Hallihan from Auburn Capital has called Telstra shares a buy following the decline since early February. Hallihan noted that Telstra recently reaffirmed its 2024 earnings guidance and revealed it's expecting underlying earnings before interest, tax, depreciation and amortisation (EBITDA) to be between $8.4 billion and $8.7 billion in FY25.

Management's plans have "shifted to re-setting and reducing costs" in markets where growth has slowed. The expert also noted that the number of postpaid mobile subscribers is approaching 9 million.

Hallihan says fair value is around $4.50 per share, according to Auburn Capital. That's around 30% higher than today's value.

Australian Clinical Labs Ltd (ASX: ACL)

This ASX 300 share is a provider of Australian pathology services to clients including doctors, specialists, patients, hospitals, and corporate clients. The company has over 70 laboratories. It's one of the country's largest private hospital pathology businesses, and the SunDoctors brand specialises in detecting skin cancer and providing treatment.

Jabin Hallihan from Auburn Capital also rated this company as a buy. He noted Australian Clinical Labs recently affirmed that underlying earnings before interest and tax is expected to be "at the lower range of between $60 million and $65 million" in FY24.

In the opinion of Hallihan and the Auburn team, the company is "undervalued" after the significant fall of the Australian Clinical Labs share price – it's down 32% in the past 12 months, as shown on the chart below.

Created with Highcharts 11.4.3Australian Clinical Labs PriceZoom1M3M6MYTD1Y5Y10YALL4 Jun 20234 Jun 2024Zoom ▾Jul '23Sep '23Nov '23Jan '24Mar '24May '24Jul '23Jul '23Oct '23Oct '23Jan '24Jan '24Apr '24Apr '24www.fool.com.au

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cheap Shares

A man reacts with surprise when her see a bargain price on his phone.
Cheap Shares

I think these 2 cheap ASX shares are buys for value investors in June

These stocks may be priced too cheaply.

Read more »

Couple looking at their phone surprised, symbolising a bargain buy.
Cheap Shares

Why I think these 2 ASX shares are steals

These investments are trading at really attractive valuations.

Read more »

Image from either construction, mining or the oil industry of a friendly worker.
Cheap Shares

Buy these 2 impressive ASX shares in June: experts

Experts are fans of these businesses. Here’s why.

Read more »

Broker working with share prices on computers.
Cheap Shares

Why UBS thinks Magellan shares could deliver a 15% return in the next year

The broker is excited about this stock.

Read more »

Happy work colleagues give each other a fist pump.
Cheap Shares

Morgans names 2 cheap ASX 200 shares to buy

The leading broker thinks these shares are being undervalued by the market.

Read more »

Happy couple looking at a phone and waiting for their flight at an airport.
Cheap Shares

2 ASX 300 shares to buy this month: experts

These stocks could be leading opportunities according to one expert.

Read more »

A senior investor wearing glasses sits at his desk and works on his ASX shares portfolio on his laptop2
Cheap Shares

Is this beaten-up stock the best value buy in the ASX 200?

An expert has outlined why this stock is an attractive opportunity.

Read more »

A woman smiles as she sits on the bus using her phone and listening to music through headphones.
Cheap Shares

2 compelling ASX shares on sale right now

These businesses look like low-priced opportunities.

Read more »